相似文献
1
The cannabinoid CB1 receptor antagonist SR141716 blocks the orexigenic effects of intrahypothalamic ghrelin.
Br J Pharmacol. 2004 Nov;143(5):520-3. doi: 10.1038/sj.bjp.0705968. Epub 2004 Sep 20.
2
Paraventricular hypothalamic CB(1) cannabinoid receptors are involved in the feeding stimulatory effects of Delta(9)-tetrahydrocannabinol.
Neuropharmacology. 2005 Dec;49(8):1101-9. doi: 10.1016/j.neuropharm.2005.03.025. Epub 2005 Aug 11.
3
Cannabinoid type-1 receptors in the paraventricular nucleus of the hypothalamus inhibit stimulated food intake.
Neuroscience. 2014 Mar 28;263:46-53. doi: 10.1016/j.neuroscience.2014.01.005. Epub 2014 Jan 13.
4
Early tolerance to the hypophagic effect of the cannabinoid receptor antagonist SR141716 does not impede blockade of an orexigenic stimulus.
Eur J Pharmacol. 2006 Aug 7;542(1-3):116-20. doi: 10.1016/j.ejphar.2006.05.028. Epub 2006 May 26.
5
CB1 receptors in the paraventricular nucleus of the hypothalamus modulate the release of 5-HT and GABA to stimulate food intake in rats.
Eur Neuropsychopharmacol. 2018 Nov;28(11):1247-1259. doi: 10.1016/j.euroneuro.2018.08.002. Epub 2018 Sep 11.
6
Role of AgRP on Ghrelin-induced feeding in the hypothalamic paraventricular nucleus.
Regul Pept. 2006 Jan 15;133(1-3):68-73. doi: 10.1016/j.regpep.2005.09.021. Epub 2005 Oct 12.
7
The orexigenic effect of ghrelin is mediated through central activation of the endogenous cannabinoid system.
PLoS One. 2008 Mar 12;3(3):e1797. doi: 10.1371/journal.pone.0001797.
8
Bi-directional CB1 receptor-mediated cardiovascular effects of cannabinoids in anaesthetized rats: role of the paraventricular nucleus.
J Physiol Pharmacol. 2015 Jun;66(3):343-53.
9
Differential modulation of endogenous cannabinoid CB1 and CB2 receptors in spontaneous and splice variants of ghrelin-induced food intake in conscious rats.
Nutrition. 2015 Jan;31(1):230-5. doi: 10.1016/j.nut.2014.06.008. Epub 2014 Jul 5.
10
Ghrelin-induced orexigenic effect in rats depends on the metabolic status and is counteracted by peripheral CB1 receptor antagonism.
PLoS One. 2013;8(4):e60918. doi: 10.1371/journal.pone.0060918. Epub 2013 Apr 2.
引用本文的文献
1
Growth hormone secretagogue receptor and cannabinoid receptor type 1 intersection in the mouse brain.
Brain Struct Funct. 2024 Dec 19;230(1):15. doi: 10.1007/s00429-024-02876-3.
2
Hypothalamic cannabinoid signaling: Consequences for eating behavior.
Pharmacol Res Perspect. 2024 Oct;12(5):e1251. doi: 10.1002/prp2.1251.
3
A genetic variant of fatty acid amide hydrolase (FAAH) exacerbates hormone-mediated orexigenic feeding in mice.
Elife. 2023 Apr 11;12:e81919. doi: 10.7554/eLife.81919.
4
Cannabidiol treatment improves metabolic profile and decreases hypothalamic inflammation caused by maternal obesity.
Front Nutr. 2023 Mar 9;10:1150189. doi: 10.3389/fnut.2023.1150189. eCollection 2023.
5
Tetrahydrocannabinols: potential cannabimimetic agents for cancer therapy.
Cancer Metastasis Rev. 2023 Sep;42(3):823-845. doi: 10.1007/s10555-023-10078-2. Epub 2023 Jan 25.
6
Impaired Ghrelin Signaling Does Not Lead to Alterations of Anxiety-like Behaviors in Adult Mice Chronically Exposed to THC during Adolescence.
Biomedicines. 2023 Jan 6;11(1):144. doi: 10.3390/biomedicines11010144.
7
The PACAP Paradox: Dynamic and Surprisingly Pleiotropic Actions in the Central Regulation of Energy Homeostasis.
Front Endocrinol (Lausanne). 2022 Jun 1;13:877647. doi: 10.3389/fendo.2022.877647. eCollection 2022.
8
The Role of Ghrelin/GHS-R1A Signaling in Nonalcohol Drug Addictions.
Int J Mol Sci. 2022 Jan 11;23(2):761. doi: 10.3390/ijms23020761.
9
Three of a Kind: Control of the Expression of Liver-Expressed Antimicrobial Peptide 2 (LEAP2) by the Endocannabinoidome and the Gut Microbiome.
Molecules. 2021 Dec 21;27(1):1. doi: 10.3390/molecules27010001.
10
Hypothalamic endocannabinoids in obesity: an old story with new challenges.
Cell Mol Life Sci. 2021 Dec;78(23):7469-7490. doi: 10.1007/s00018-021-04002-6. Epub 2021 Oct 31.
本文引用的文献
1
Endogenous cannabinoids and appetite.
Nutr Res Rev. 2001 Jun;14(1):65-86. doi: 10.1079/NRR200118.
2
Ghrelin--a hormone with multiple functions.
Front Neuroendocrinol. 2004 Apr;25(1):27-68. doi: 10.1016/j.yfrne.2004.03.002.
3
Evidence for an interaction between CB1 cannabinoid and melanocortin MCR-4 receptors in regulating food intake.
Endocrinology. 2004 Jul;145(7):3224-31. doi: 10.1210/en.2004-0059. Epub 2004 Mar 19.
4
The endogenous cannabinoid, anandamide, activates the hypothalamo-pituitary-adrenal axis in CB1 cannabinoid receptor knockout mice.
Neuroendocrinology. 2003 Dec;78(6):294-300. doi: 10.1159/000074882.
5
Nongenomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: a fast feedback mechanism.
J Neurosci. 2003 Jun 15;23(12):4850-7. doi: 10.1523/JNEUROSCI.23-12-04850.2003.
6
The cannabinoid receptor antagonist SR 141716 attenuates overfeeding induced by systemic or intracranial morphine.
Psychopharmacology (Berl). 2003 Jul;168(3):314-23. doi: 10.1007/s00213-003-1451-9. Epub 2003 Apr 17.
7
Endogenous cannabinoid system as a modulator of food intake.
Int J Obes Relat Metab Disord. 2003 Mar;27(3):289-301. doi: 10.1038/sj.ijo.0802250.
8
The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis.
Neuron. 2003 Feb 20;37(4):649-61. doi: 10.1016/s0896-6273(03)00063-1.
9
Ghrelin injected into the paraventricular nucleus of the hypothalamus of male rats induces feeding but not penile erection.
Neurosci Lett. 2002 Sep 6;329(3):339-43. doi: 10.1016/s0304-3940(02)00673-0.
10
Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol.
Br J Pharmacol. 2002 Jun;136(4):550-7. doi: 10.1038/sj.bjp.0704767.
Zotero 插件